Skip to main content
. 2020 Apr 19;12(4):1005. doi: 10.3390/cancers12041005

Table 3.

Concordance of CTC status between the metabolism-based assay (MBA) and CellSearch (CS) method at baseline (T0) and follow-up (T1), using respective cut-offs.

Left Panel Right Panel
Time-Point Cell Population Cut-Off CS Tot Time-Point Cell Population Cut-Off CS Tot
<5 ≥5 <5 ≥5
T0 a T0 c
MBA <6 10 3 13 MBA-E+ <6 12 4 16
≥6 4 5 9 ≥6 2 4 6
Tot 14 8 22 Tot 14 8 22
T1 b T1 d
MBA <6 11 3 14 MBA-E+ <6 14 3 17
≥6 5 2 7 ≥6 2 2 4
Tot 16 5 21 Tot 16 5 21

a Kappa = 0.330 (fair agreement); SE of kappa = 0.205; 95% CI from −0.071 to 0.732; Number of observed agreements: 15 (68.2% of the observations); b Kappa = 0.077 (poor agreement); SE of kappa = 0.218; 95% CI from −0.351 to 0.504; Number of observed agreements: 13 (61.9% of the observations); c Kappa = 0.377 (fair agreement); SE of kappa = 0.205; 95% CI from −0.025 to 0.780; Number of observed agreements: 16 (72.7% of the observations); d Kappa = 0.295 (fair agreement); SE of kappa = 0.243; 95% CI from −0.180 to 0.771; Number of observed agreements: 16 (76.2% of the observations).